Studies on the pathology, especially brain hemorrhage and angioendotheliomas, induced by two new mos-containing viruses

Journal of NeuroVirology

Volumn 6, Issue 2, 2000, Pages 106-120

  Lim, Kit Yeng ^a   Ryan, Esther A ^a   Wong, Paul K Y ^a   Yuen, Pick Hoong ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Angioendotheliomas; Brain hemorrhage; Genes; v mos; Vascular endothelium

Indexed keywords

LECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HEMORRHAGE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMANGIOENDOTHELIOMA; LECTIN BINDING; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SARCOMA VIRUS; SPLEEN TUMOR; SUBCUTANEOUS TISSUE TUMOR; VIRUS ONCOGENE;

ANIMALIA; BANDEIRAEA; BANDEIRAEA SIMPLICIFOLIA; MOLONEY MURINE SARCOMA VIRUS; MURINAE; MYELOPROLIFERATIVE SARCOMA VIRUS; TUMOR VIRUS;

EID: 0034024623     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280009013154     Document Type: Article

References (37)

1. Alroy J, Goyal V, Skutelsky E (1987). Lectin histochemistry of mammalian endothelium. Histochemistry 86: 603-607.
2. Belloni PN, Tressler RJ (1990). Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells. Cancer Metastasis Rev 8: 353-389.
3. Bold RJ, Donoghue DJ (1985). Biologically active mutants with deletions in the v-mos oncogene assayed with retroviral vectors. Mol Cell Biol 5: 3131-3138.
4. Carroll Jr JT, Schelper RL, Goeken JA, Kemp JD (1986). Neoplastic angioendotheliomatosis: immunopathologic and morphologic evidence for intravascular malignant lymphomatosis. Am J Clin Pathol 85: 169-175.
5. Coffin JD, Harrison J, Schwartz S, Heimark R (1991). Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. Dev Biol 148: 51-62.
6. Hayashi Y, Tange T, Urano Y, Smadja-Joffe F, Le Bousse-Kerdiles MC, Jasmin C (1988). Histopathologic studies on myeloproliferative sarcoma virus (MPSV) induced leukemias and hemangiosarcoma in Jar-2 rats. Pathol Res Pract 183: 314-320.
7. Hilberg F, Stocking C, Ostertag W, Grez M (1987). Functional anlaysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proc Natl Acad Sci USA 84: 5232-5236.
8. Kennedy MT, Brockman H, Rusnak F (1996). Contributions of myristoylation to calcineurin structure/function. J Biol Chem 271: 26517-26521.
9. Knighton DR, Zheng J, Ten Eyck LF, Ashford VA, Xuong NH, Taylor SS, Sowadski JM (1991). Crystal structure of the catalytic subject of cyclic adenosine monophosphate-dependent protein kinase. Science 253: 407-414.
10. Laitinen L (1987). Griffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues. Histochem J 19: 225-234.
11. Mann R, Mulligan RC, Baltimore D (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33: 153-159.
12. Maxwell SA, Arlinghaus RB (1985). Serine kinase activity associated with Moloney murine sarcoma virus-124-encoded p37mos. Virology 143: 321-333.
13. Moloney JB (1966). A virus-induced rhabdomyosarcoma of mice. Natl Cancer Inst Monogr 22: 139-142.
14. Propst F, Cork LC, Kovatch RM, Kasenally AB, Wallace R, Rosenberg MP (1992). Progressive hind limb paralysis in mice carrying a v-Mos transgene. J Neuropathol Exp Neurol 51: 499-505.
15. Propst F, Rosenberg MP, Cork LC, Kovatch RM, Rauch S, Westphal H, Khillan J, Schulz NT, Neumann PE, Newmann PE (1990) Neuropathological changes in transgenic mice carrying copies of a transcriptionally activated Mos protooncogene [published erratum appears in Proc Natl Acad Sci USA 1991 May 1; 88(9):4060]. Proc Natl Acad Sci USA 87: 9703-9707.
16. Ribacchi R, Giraldo G (1966). Plasmacytomas occurring in the bones of rats injected intracerebrally with murine sarcoma virus (MSV). Moloney' strain. Preliminary report. Lav Ist Anat Istol Patol Perugia 26: 149-156.
17. Robertson SC, Donoghue DJ (1996). Identification of an autoinhibitory region in the activation loop of the Mos protein kinase. Mol Cell Biol 16: 3472-3479.
18. Sahagun G, Moore SA, Fabry Z, Schelper RL, Hart MN (1989). Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled griffonia simplicifolia agglutinin. Am J Pathol 134: 1227-1232.
19. Singh B, Stocking C, Walker R, Yang YD, Ostertag W, Arlinghaus RB (1992). v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant. J Virol 66: 1267-1272.
20. Singh B, Hannink M, Donoghue DJ, Arlinghaus RB (1986). p37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos. J Virol 60; 1148-1152.
21. Slice LW, Taylor SS (1989). Expression of the catalytic subunit of cAMP-dependent protein kinase in Escherichia coli. J Biol Chem 264: 20940-20946.
22. Stacey A, Arbuthnott C, Kollek R, Coggins L, Ostertag W (1984). Comparison of myeloproliferative sarcoma virus with moloney murine sarcoma virus variants by nucleotide sequencing and heteroduplex analysis. J Virol 50: 725-732.
23. Stanton MF, Law LW, Ting RG (1968). Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. II. Morphologic studies. J Natl Cancer Inst 40: 1113-1129.
24. Stocking C, Kollek R, Bergholz U, Ostertag W (1985). Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma viruses. Proc Natl Acad Sci USA 82: 5746-5750.
25. Stocking C, Kollek R, Bergholz U, Ostertag W (1986). Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus. Virology 153: 145-149.
26. Stoica G, Hoffman J, Yuen PH (1990). Moloney murine sarcoma virus 349 induces Kaposi's sarcomalike lesions in BALB/c mice. Am J Pathol 136: 933-947.
27. Taylor SS, Radzio-Andzelm E (1994). Three protein kinase structures define a common motif. Structure 2: 345-355.
28. Toda K, Tsujioka K, Maruguchi Y, Ishii K, Miyachi Y, Kuribayashi K, Imamura S (1990). Establishment and characterization of a tumorigenic murine vascular endothelial cell line (F-2). Cancer Res, 50: 5526-5530.
29. Van Beveren C, van Straaten F, Galleshaw JA, Verma IM (1981). Nucleotide sequence of the genome of a murine sarcoma virus. Cell 27: 97-108.
30. Vinores SA, Herman MM, Perentes E, Nakagawa Y, Thomas CB, Innes DJ, Rubinstein LJ (1992). The growth of two murine hemangioendotheliomas intracranially, subcutaneously, and in culture, and their comparison with human cerebellar hemangioblastomas: morphological and immunohistochemical studies. Acta Neruopathol 84: 67-77.
31. Wong PK, Soong MM, Yuen PH (1981). Replication of murine leukemia virus in heterologous cells: interaction between ecotropic and xenotropic viruses. Virology 109: 366-378.
32. Yew N, Oskarsson M, Daar I, Blair DG, Vande Woude GF (1991). mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities. Mol Cellular Biol 11: 604-610.
33. Yuen PH, Kwak YT (1997). R7, a spontaneous mutant of Moloney murine sarcoma virus 124 with three direct repeats and an in-frame truncated gag-mos gene, induces brain lesions. Virology 236: 213-218.
34. Yuen PH, Kwak YT (1998). Studies on the pathology, especially brain lesions, induced by R7, a spontaneous mutant of Moloney murine sarcoma virus 124. Am J Pathol 152: 1509-1520.
35. Yuen PH, Khang YH, Kumar A, Szurek PF, Maull EA (1991a). The Moloney murine leukemia virus enhancer and its flanking sequences collaborate to determine virulence in T-cell lymphomagenesis. Mol Carcinog 4: 72-80.
36. Yuen PH, Matherne CM, Molinari-Storey LM (1991b). SV7, a molecular clone of Moloney murine sarcoma virus 349, transforms vascular endothelial cells. Am J Pathol 139: 1449-1461.
37. Yuen PH, Szurek PF (1989). The reduced virulence of the thymotropic Moloney murine leukemia virus derivative MoMuLV-TB is mapped to 11 mutations within the U3 region of the long terminal repeat. J Virol 63: 471-480.